Director of Stoke Therapeutics, Inc. (NASDAQ:STOK), Harrison Seth Loring, buys 375,000 shares worth $14,625,000

According to Stoke Therapeutics, Inc.'s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Nov 25 05:03 PM, company Director, Harrison Seth Loring disclosed buying 375,000 shares at a cost of $39.00. At the time of this transaction (Nov 24), this trade was worth $14,625,000 in total. As of Nov 24, Harrison Seth Loring now owns 17,161,713 shares in total worth about $823,590,606.87.

For the last few recent trades made by Stoke Therapeutics, Inc. (NASDAQ:STOK) Director, Harrison Seth Loring, we have the following information:

Posted by George Daniels on Wednesday November 25 2020, 6:37 PM EDT. All trademarks acknowledged. Filed under Business, Stocks. Comments and Trackbacks closed. Follow responses: RSS 2.0